A detailed history of New Vernon Capital Holdings Ii LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, New Vernon Capital Holdings Ii LLC holds 2,697 shares of UTHR stock, worth $971,351. This represents 0.52% of its overall portfolio holdings.

Number of Shares
2,697
Previous 2,697 -0.0%
Holding current value
$971,351
Previous $859,000 12.46%
% of portfolio
0.52%
Previous 0.46%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $19,389 - $22,954
92 Added 3.53%
2,697 $619,000
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $559,762 - $669,328
2,605 New
2,605 $572,000
Q1 2019

May 13, 2019

SELL
$107.15 - $126.84 $360,666 - $426,943
-3,366 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$101.4 - $128.73 $81,829 - $103,885
807 Added 31.54%
3,366 $367,000
Q2 2018

Aug 14, 2018

BUY
$101.14 - $118.31 $258,817 - $302,755
2,559 New
2,559 $290,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track New Vernon Capital Holdings Ii LLC Portfolio

Follow New Vernon Capital Holdings Ii LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Vernon Capital Holdings Ii LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Vernon Capital Holdings Ii LLC with notifications on news.